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The human immunodeficiency virus (HIV) continues to be a leading 
cause of death in sub-Saharan Africa, with South Africa (SA) having 
the highest number of people living with HIV. Countries with a high 
prevalence of HIV, mainly those in sub-Saharan Africa, have witnessed 
an increase in tuberculosis (TB) cases. High TB and HIV co-infection 
rates have been reported in SA. In 2009, more than 60% of TB patients 
in SA were reported to be co-infected with HIV,[1] the figure reaching 
nearly 80% in Hlabisa sub-district.[2] HIV in TB patients increases 
mortality, promotes progression of latent and recently acquired TB to 
active TB, and increases TB recurrence rates. [1]
TB patients face several challenges in accessing care, and an integrated 
service that includes HIV testing is most likely to ensure timely 
initiation of HIV treatment and optimal TB care. The need to integrate 
TB and HIV programmes was highlighted in 2004 by the World Health 
Organization (WHO)’s HIV and Stop TB departments, and from 
2009 onwards WHO guidelines recommended that all HIV-positive 
patients with active TB start antiretroviral therapy (ART) immediately. [3] 
Integrated TB/HIV activities, including HIV testing of all TB patients, 
can help ensure that HIV-positive TB patients are identified and 
treated appropriately and help prevent TB in HIV-positive patients,[1] 
thereby accelerating universal access to comprehensive TB and HIV 
prevention, treatment and care.[4] HIV testing rates among TB patients 
differ according to approaches used (voluntary or provider-initiated 
testing) and the setting, with higher rates being reported in integrated 
as opposed to vertical programmes.[5,6]
Vertical models are those in which HIV or TB services stand 
alone and cross-refer patients to the other service for testing and 
treatment. Programmes can be integrated in respect of funding, 
management, service delivery, and monitoring and evaluation of 
health systems.[7,8] From the patient’s perspective it is most important 
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that TB and HIV services are provided in the same facility.[6,9,10] 
Facility-level integration in the delivery of TB and HIV services 
has been adopted in the primary healthcare clinics (PHCs) in the 
Hlabisa sub-district of KwaZulu-Natal.[6] Benefits of such integration 
include increased satisfaction and reduced time and financial costs 
for patients receiving care for both diseases.
Understanding factors that influence availability and utilisation 
of healthcare is essential in providing comprehensive healthcare 
services. Multiple factors potentially affect healthcare utilisation 
among TB patients, including HIV testing uptake; some of these are 
patient socio-demographic characteristics, availability of services 
(e.g. directly observed treatment, short course (DOTS)), physical/
geographical variables (e.g. travel time, mode of transport), and 
organisational issues (e.g. opening times of clinics). The aim of 
this study was to investigate factors affecting healthcare availability 
and utilisation, including uptake of HIV testing, in TB patients in a 
programme devolved to rural PHCs in the Hlabisa sub-district.
Methodology
Setting
The Department of Health TB (DoH-TB) control programme 
operates at the Hlabisa district hospital (DH) and 17 PHCs. The 
programme is integrated with the Hlabisa HIV Treatment and 
Care Programme (ART programme), which receives additional 
staff support and database management from the Africa Centre for 
Health and Population Studies (www.africacentre.com).[6,11] The ART 
programme utilises a decentralised approach with integration of TB 
and HIV services to primary healthcare, linking treatment, care and 
prevention services.[11]
TB nurses at each PHC identify TB suspects and collect sputum, 
which is sent to the National Health Laboratory Service (NHLS) 
for acid-fast bacilli smear testing. All smear-positive patients are 
initiated onto the first-line standard TB regimen, and patients with 
negative smears (most of whom are HIV-infected) who remain 
symptomatic are referred to the DH for further clinical assessment 
and X-rays. [2,6] The DoH-TB control programme adheres to national 
guidelines on the diagnosis, treatment and care of TB patients. All TB 
patients requiring inpatient services or those with complications, as 
well as those with multidrug-resistant (MDR) and extensively drug-
resistant (XDR) TB, are referred to the DH. After completing their 
hospitalisation (typically 1 month), patients are treated  daily on an 
outpatient basis, with monthly clinic follow-up.
Since the end of 2009, a routine opt-out provider-initiated approach 
for HIV testing and counselling (PITC) has been in place at all PHCs 
in the sub-district, in addition to established voluntary counselling 
and testing.[11,12] A rapid HIV test is performed in patients who 
agree to be tested, and blood samples from HIV-positive patients are 
sent to the NHLS for CD4 cell counts. Results are available within 
2 days and patients are requested to return to the clinic for their 
CD4 count results within a week of sample collection. Individuals 
who are not yet eligible for ART are monitored and followed up 
regularly. Prior to ART initiation, patients are screened for TB and 
other opportunistic infections, which are treated appropriately when 
diagnosed. ART initiation, treatment and care are offered according 
to the national guidelines.
As part of a larger multisite cross-sectional study called Researching 
Equity in ACcess to Healthcare (REACH), which was conducted in four 
sub-districts in SA in 2009 to examine barriers to healthcare access,  we 
collected data on factors affecting healthcare availability and utilisation, 
including uptake of HIV testing in adults with TB attending PHCs in 
Hlabisa sub-district.
Sampling and sample size
We randomly selected patients in a two-stage-sampling scheme, with 
five PHC sampling units selected with probability proportional to size, 
and collected data through exit interviews with 300 patients utilising 
TB treatment at the selected PHCs. Three clinics that had some 
ongoing research activities were excluded from the sampling frame 
of the then 16 PHCs in the sub-district, to avoid over-burdening staff 
and patients.
Data collection
A structured questionnaire was administered to patients in isiZulu by 
four trained fieldworkers. Written consent was obtained from patients 
aged 18 years and above who volunteered to participate and had been 
on TB treatment for at least 2 months (by which time they would be 
expected to have completed the intensive phase of treatment). Those 
patients with MDR/XDR TB and who received treatment in hospital 
for the first 2 months were therefore also captured for this study, having 
been referred for follow-up treatment at the PHC. The study received 
ethical clearance from the University of KwaZulu-Natal (BE174/08). 
Statistical methods
Summary statistics on the variables collected are set out in Table 1. 
Further, we regressed the binary variable indicating whether an HIV 
test was offered on a range of independent variables in multivariable 
logistic regression to gain insights on the predictors of HIV testing in 
this patient population. All analyses were done using STATA (Release 
Version 11, Stata Corporation, College Station, TX) and values of 
p<0.05 were considered significant.
Results
Table 1 shows the socio-demographic profile of patients utilising TB 
healthcare at the PHCs, as well as summary statistics on aspects of 
TB-related care. The majority of patients (75.2%) were receiving care 
for a first episode of TB, in most cases pulmonary. Almost all patients 
(94.3%) reported having been offered an HIV test during the current 
TB treatment episode, most had been diagnosed with TB at the same 
clinic at which they were receiving their TB treatment, and almost all 
(95.8%) stated that they were able to access other healthcare services 
at the same facilities they utilised for their TB treatment. Although 
most patients were supported by DOTS, 20.3% did not take their TB 
medication under observation.
Almost all patients (97.0%) were accessing the clinic closest to their 
home for TB treatment. Self-reported reasons for not using the closest 
clinic were that the clinic they attended was closer to their workplace 
(n=2), that they were offered good service at the present clinic (n=1), 
that the nearest clinic did not give correct treatment (n=1) or had too 
many patients and long queues (n=1), lack of knowledge on how to 
change clinics (n=1), treatment course almost completed and therefore 
no need to change clinics (n=1), and changes in place of residence after 
initiating TB treatment at the present clinic (n=2). More than a tenth 
of patients receiving TB care asserted that people in the community 
judged them negatively for attending for TB treatment.
Among the 9 patients who were not using their closest clinic, 2 
(22.2%) were female, the median age was 39 years (interquartile 
range (IQR) 35 - 48 years), 5 (55.6%) had little or no education, 
6 had never married (66.7%) and 7 (77.8%) were unemployed. 
Controlling for age, sex, education, marital status, employment and 
other factors associated with being offered an HIV test, patients 
using their closest clinic were substantially more likely to have 
been offered HIV testing than those not using their closest clinic 
(adjusted odds ratio 12.79, p=0.05).
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The average travel time for patients attending a clinic was 2 hours 
for a return trip, and most of them used a minibus taxi (Fig. 1). The 
median time taken to travel (return trip) to the clinic on foot or by 
public transport was 90 minutes (IQR 60 - 180 minutes), by own car 
60 minutes (IQR 40 - 75 minutes) and by other private car (a hired car 
or catching a lift) 120 minutes (IQR 60 - 120 minutes). (‘Other private 
car’ refers to a personal car that usually transports people from typically 
inaccessible areas where there is no public transport. Individuals hire 
these cars, or wait for them at pick-up points, or obtain lifts on their 
way to the destination point.) 
We analysed the 17 patients who were not offered HIV testing 
according to socio-demographic characteristics, and found that 10 
(58.8%) were female and the median age was 33 years (IQR 30 - 
49 years). A high proportion had never been married (13, 76.5%) 
and were unemployed (16, 94.1%), and 3 (17.7%) had no formal 
education. There was no statistically significant difference in the 
socio-demographic profile of those offered and not offered HIV 
testing, but statistical power to detect such differences was low due to 
the study sample size.
Discussion and conclusion
In an area with a high burden of TB and HIV, we found near-universal 
HIV testing among TB patients attending PHCs in a rural programme 
devolved to primary care level. Few people refused the offer of HIV 
testing once they had received counselling on the importance of 
knowing their HIV status for optimal general medical care and TB 
treatment. The HIV testing rate had risen to 94%[13] from the previously 
reported 88%,[6,11] with an age-sex profile comparable to previous 
studies in the area.[2,6] There was no significant difference in terms 
of socio-demographic characteristics between patients not offered an 
HIV test and those offered one, indicating that health workers were 
following the TB guidelines on HIV screening satisfactorily and have 
adopted a successful PITC approach.
Table 1. Availability and utilisation of TB treatment and care 
services in primary healthcare clinics (N=296)
Patient socio-demographic characteristics 
Gender, n (%)
Female 156 (52.7)
Age (years), n (%)
Mean (95% CI) 38 (37 - 39)
<20 - 29 73  (24.7)
30 - 39 102 (34.5)






Matric and higher 53 (17.9)
Employed (n=295), n (%)
Yes 28 (9.5)
Marital status, n (%)
Never married 249 (84.1)
TB healthcare-related factors
Is this the first time you have had TB? (N=294), n (%)
Yes 221 (75.2)
Have you been offered an HIV test (during this 
current treatment episode), n (%)
Yes 279 (94.3)
Besides TB care, are you able to get the other health 
services you need in this facility? (N=286), n (%)
Yes 274 (95.8)
Who checks that you have taken your TB treatment 
each day? n (%)
The TB DOTS sister or counsellor 102 (34.5)
A community worker (community DOTS) 12 (4.1)
Someone at my place of work (workplace DOTS) 4 (1.4)
No one 60 (20.3)
Family members/partners/neighbours 118 (40.0)
Do you feel that people in the community judge 
you negatively for attending this facility for your TB 
treatment? (N=257), n (%)
Yes 31 (12.1)
Since you first started coming to this facility, have you 
ever left without being helped? (N=296), n (%)
Yes 38 (12.8)
During this current treatment episode, have you 
received treatment from a clinic other than this 
one? (N=293), n (%)
Yes 40 (13.7)
Apart from the past 3 days, have you ever missed  
taking any tablets? (N=293), n (%)
Yes 10 (3.4)
Table 1 (continued). Availability and utilisation of TB 
treatment and care services in primary healthcare clinics 
(N=296)
TB healthcare-related factors
Are the opening hours of this clinic convenient  
for you? n (%)
Yes 291 (99.3)
Is this the closest clinic to your home that offers 
TB treatment? n (%)
Yes 287 (97.0)
How long does it take you to get here (clinic) and 
return? (minutes), mean (95% CI)
120 (109.6 - 
129.9)
















Fig. 1. Modes of transport used by patients (%) to travel to the primary 
healthcare clinics to receive TB treatment (N=296).
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Integration of TB and HIV services with primary healthcare services 
ensures patient accessibility to comprehensive healthcare and also 
strengthens health systems, in turn achieving improved universal access 
to health.[4,6,14] Almost all patients in our study confirmed their ability to 
utilise the other healthcare services they required from the same facility 
at which they obtained their TB treatment. Joint delivery of TB and HIV 
in PHCs serves to support good accessibility (encompassing availability 
and utilisation of services) to comprehensive healthcare. However, some 
TB healthcare services need to be improved in respect of DOTS delivery 
to ensure sustained adherence to treatment.[4,14] While the TB programme 
has not received the same level of support as the ART programme,[6] 
further research is needed to understand the imperfections in TB 
DOTS coverage identified in this study. Significantly, the gap in the 
DOTS delivery system creates an opportunity to strengthen the current 
TB programme, e.g. through community-based linkages and DOTS 
support on the part of policymakers and district management teams, as 
proposed in efforts to reform the SA health system.
Patients generally use the clinic closest to their homes for TB 
treatment and HIV testing, implying that fear of stigma appears not 
to play a major role in their decision where to seek health care. This 
conclusion is supported by the fact that reasons for not using the clinic 
closest to home included better quality of care, shorter waiting time 
and queues, and closeness to place of work. The few patients who did 
not test for HIV at their closest clinic may have been diagnosed with 
resistant TB and hospitalised; they would have been offered HIV testing 
while treatment was initiated, and their results sent to the nearest clinic 
from the hospital. Our study area has experienced sustained high levels 
of both HIV and TB, as well achieving high coverage of treatment of 
both diseases; in 2010, 25% of people in the area shared a household 
with someone receiving ART.[15]  Social exposure to people receiving 
treatment may have normalised attitudes and behaviours towards HIV 
and TB. Integration of HIV and TB services in PHCs, as well as PITC, is 
also likely to have reduced stigma.
The average travelling time for TB patients attending PHCs in 
Hlabisa sub-district was 2 hours for a return trip, and most used 
minibus taxis. The time losses arising from TB treatment are a potential 
threat to treatment uptake and retention. In this context, the time saved 
in utilising combined TB and HIV treatment at the same PHC, instead 
of in geographically separate locations, is likely to have had a positive 
impact on healthcare access by co-infected patients. Policymakers could 
consider providing subsidised transport for patients, and increasing the 
geographical density of PHCs in rural areas where possible.
In conclusion, this study demonstrates that in a devolved 
integrated public sector programme, TB and HIV services can be 
integrated successfully at the level of the rural PHC. The high HIV 
testing rates among TB patients indicate that patients co-infected 
with the two diseases are clearing the first hurdle to adequate 
treatment of HIV infection, and that service integration has the 
potential subsequently to ensure their appropriate management. 
However, research is needed on whether TB patients who test 
positive for HIV do indeed return for their CD4 count results and 
ART. Findings on factors affecting healthcare utilisation, such as 
DOTS, adherence and patient accessibility to clinics, could further 
inform activities deserving the focus of the district management 
teams proposed as part of the SA health system reform.
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